FDA approval to addition of OS Data in labelling of Gilteritinib

-

The US Food and Drug Administration has approved the addition of overall survival (OS) data in labelling process of Gilteritinib, a cancer drug which was indicated for adult patients who had relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. FLT3 is a receptor tyrosine kinase with important roles in cell survival and proliferation. It is mutated in one -third of AML patients. Gliteritinib acts as an inhibitor of AXL receptor tyrosine kinase, an enzyme in humans encoded by AXL gene . The AXL gene plays a crucial role in facilitating immune escape and drug resistance by cancer cell, leading to metastatic cancers.  

According to results, treatment with the FLT3-targeted therapeutic Gilteritinib has shown improved survival for patients with relapsed or refractory acute myeloid leukemia harbouring an FLT3 mutation compared with standard chemotherapy regiments.

Get to know more such interesting news about oncology at: https://bit.ly/2KYdGMJ


Comments

Post a Comment

Popular posts from this blog

-
Image
Researchers have found that artificial intelligence recognizes new breast cancer types that respond differently to a treatment. Using artificial intelligence, five new types of diseases were uncovered, each of them matched to different personalized treatments. The study applied AI and a machine-learning approach to gene sequences and molecular data from breast tumors, to reveal crucial differences among cancers that had previously been lumped into one type of disease. The researchers applied the AI-compatible computer software to a vast array of data available in the field of genetics, a molecular and cellular constituent of breast tumors, and data on patient survival. The goal of the study is to apply this technique different types of cancer and get information about their response and sensitivity to treatment, part of evolution, and how to tackle drug resistan problem.          
Read more

Basic Concepts of Cancer

-
Image
Cancer is a group of diseases involving abnormal growth of cells which tend to proliferate in an uncontrolled way and, in cases, to metastasize(spread). It is caused by certain changes to genes, the basic physical unit of inheritance, that control the way cells function, especially how   they grow and divide.   Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place. When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumors.     Cancer     can involve any tissue of the body and have many different forms in each body area. Most cancers are named for the type of cell or organ in they start.
Read more